April 21, 2023 FDA authorizes changes to simplify use of bivalent mRNA COVID-19 vaccines Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals.
Aug. 31, 2022 FDA authorizes Moderna, Pfizer-BioNTech bivalent COVID-19 vaccines for use as a booster dose The U.S. Food and Drug Administration amended the emergency use authorizations of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine to authorize bivalent formulations of the vaccines for use as a single booster dose at least two months following primary or booster vaccination.
Aug. 23, 2022 CDC recommends Novavax COVID-19 vaccine for adolescents Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo that Novavax’s COVID-19 vaccine be used as another primary series option for adolescents ages 12 through 17.
Aug. 22, 2022 Eligible Airmen, Guardians have access to more monkeypox vaccines The Department of Defense is increasing its supply of the approved monkeypox vaccine, JYNNEOS, which allows for more Airmen and Guardians at higher risk for transmission to access preventive measures to keep themselves safe.
Aug. 4, 2022 Air Force, Space Force members at high risk for monkeypox urged to stay informed The current outbreak of monkeypox continues to spread, with more than 6,600 active cases in the United States mostly occurring among gay and bisexual men. The White House declared on August 4 that monkeypox is a national public health emergency.
July 28, 2022 Monkeypox declared public health emergency: What Airmen and Guardians need to know The World Health Organization declared monkeypox a public health emergency on July 23. With more than 4,000 cases in the United States, Airmen and Guardians should know the risks and how to stay safe.
July 20, 2022 Air Force prepares for newly approved COVID-19 vaccine: Novavax provides new option for unvaccinated Airmen, Guardians The Air Force will soon have the Novavax COVID-19 vaccine available after the U.S Food and Drug Administration authorized it for emergency use and the Centers for Disease Control and Prevention endorsed it as another primary series option for adults ages 18 years and older.
Oct. 29, 2021 FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in children 5 through 11 years of age Today, the U.S. Food and Drug Administration authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age. The authorization was based on the FDA’s thorough and transparent evaluation of the data that included input
March 1, 2021 FDA issues emergency use authorization for third COVID-19 vaccine Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be
Dec. 1, 2020 COVID-19 Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna Inc.
Nov. 17, 2020 COVID-19 Update: FDA’s Ongoing Commitment to Transparency for COVID-19 EUAs Emergency use authorizations, or EUAs, are an important tool in our country’s fight against COVID-19 and other public health emergencies. While EUAs have received increased attention during the COVID-19 public health emergency, EUAs are not a new tool to the FDA. I want to take a moment to reaffirm
Nov. 19, 2019 Air Force says CBD products not ok to use, may cause positive drug test Cannabidiol oil, also known as CBD oil, is growing in popularity as an ingredient in health and pet products, but is it okay for service members and federal employees to use? The simple answer is no.
Sept. 12, 2019 Health agencies investigating severe lung illnesses linked to e-cigarette use The Centers for Disease Control and Prevention is working with the Food and Drug Administration, state and local health departments, and other public health partners to investigate a multistate outbreak of severe lung illnesses linked to e-cigarette use.As of Sept. 6, the CDC said, 33 states as well
April 29, 2019 Voluntary Drug Recall Alert: Fentanyl On April 19, 2019, the Food and Drug Administration (FDA) announced a voluntary recall of a small number of cartons labeled Fentanyl 12 mcg/h Transdermal System patches. Fentanyl is used to manage pain for patients who can tolerate opioids.
Aug. 23, 2018 FDA takes additional action to mitigate shortages of EpiPen by extending expiration date for specific lots of medication Due to the intermittent supply interruptions of EpiPen, FDA is alerting health care professionals and patients of updated dates through which some EpiPens and the authorized generic version, manufactured by Meridian Medical Technologies, a Pfizer company, may be used beyond the manufacturer’s
March 15, 2018 First-ever blood test for detecting brain injury cleared by FDA You’re throwing a football around in the yard with your neighbors. While stretching out as far as you can to catch the pass, you slam your head hard against a pole going for the ball. Seeing stars and feeling confused, you take a seat. Wouldn’t it be nice if a test could say whether you have a brain
July 23, 2015 Get Answers to Your Medication Questions Have you ever picked up a prescription, got home and realized you had a question? Maybe you had a headache but weren’t sure how the pain reliever would work with another medication you take? You’re not alone. “Your safety is important to us. Don’t be afraid to call and ask your doctor or pharmacist